Top compounds associated with response to GPR141


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib gCSI pan-cancer AAC -0.14 0.01
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.01
mRNA erastin CTRPv2 pan-cancer AAC -0.084 0.01
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.01
mRNA prima-1 CTRPv2 pan-cancer AAC -0.074 0.02
mRNA L-685458 CTRPv2 pan-cancer AAC -0.087 0.02
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.02
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.02
mRNA BMS-536924 CTRPv2 pan-cancer AAC 0.083 0.02
mRNA GDC-0879 CTRPv2 pan-cancer AAC 0.081 0.02
Download CSV